Pharmacists' Role in Diabetes Care

Dear Colleagues,

Diabetes is a world-wide public health threat and challenge. Recent estimates suggest that by 2045, nearly 700 million people will have diabetes around the world. Moreover, it is possible that this number will be even higher, as rates of obesity continue to increase.

Pharmacists have always played an integral role in helping patients with diabetes more effectively manage this condition. Whether in the form of educating patients about the importance of adhering to their prescribed medications, training patients in self-management techniques, actively modifying medication therapies to ensure patients receive the best possible outcomes, or many other activities, pharmacists have played many, many roles in the care of patients with diabetes. This Special Issue will provide a snap shot of pharmacists’ current role in the care of patients with diabetes, show evidence of the value of pharmacists interventions to health systems, demonstrate how evidence-based interventions are being spread across various pharmacy settings, and provide new directions for future research into this important topic. We are seeking submissions from those involved in observational studies, clinical or practice trials, economic evaluations, implementation science trials, or surveys of the current pharmacy literature about the care of patients with diabetes, who can provide new ideas for how pharmacists can be even more effective. Our objective is to consolidate the current and best available evidence pertaining to all aspects of pharmacists’ interventions in the care of this population, to acknowledge previous work and the value created to date, and provide a road map to researchers and practitioners for how to maximize pharmacists’ benefit to all patients who have diabetes.

Prof. Dr. Meagen Rosenthal
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Diabetes;
• Pharmacists’ diabetes care;
• Interventions by pharmacists;
• Pharmacy practice change management;
• Pharmacists’ value.